BDBM183405 US9145354, 1
SMILES: CC[C@@H](N)c1ccc(Cl)c(C(=O)c2ccc(N)nc2)c1F
InChI Key: InChIKey=AGDWLPGIOLJTDZ-LLVKDONJSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
HCV NS3-NS4A Serine Proteinase (Hepatitis C virus (HCV genotype 1a, isolate H)) | BDBM183405 (US9145354, 1) | PDB MMDB UniProtKB/SwissProt B.MOAD DrugBank GoogleScholar AffyNet | PC cid PC sid UniChem Similars | US Patent | n/a | n/a | 89 | n/a | n/a | n/a | n/a | n/a | 25 |
ASTEX THERAPEUTICS LIMITED US Patent | Assay Description The HCV NS3 protease functions have been extensively studied and are considered as potential targets for antiviral therapy: see for example the many ... | US Patent US9145354 (2015) BindingDB Entry DOI: 10.7270/Q2VH5MMZ | |||||||||||
More data for this Ligand-Target Pair |